Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost Ocular Insert OLE 2 in Glaucoma/Ocular Hypertension
NCT02537015Phase 2Completed
- Sponsor
- ForSight VISION5
- Start
- Aug 2015
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bimatoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by ForSight VISION5. Started Aug 2015; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02537015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537015.